申请人:Pierre Fabre Medicament
公开号:US08022064B2
公开(公告)日:2011-09-20
The present invention relates to compounds of general formula (I): wherein: R1 and R2, identical or different, represent: an atom of hydrogen or halogen, CN or NO2, with R1 and R2 not representing hydrogen simultaneously, m represents: 1 or 2 n represents: 0, 1 or 2 R3 represents: phenyl substituted or not by one or more residues chosen among halogen, hydroxyl or C1-C6 alkyl; C2-C6 alkyl substituted or not by one or more residues chosen among halogen or hydroxyl; cycloalkyl; pyridine; thiophene; pyrrole substituted or not by C1-C6 alkyl; thiazole or furan; or the therapeutically-acceptable salts or solvates thereof.
本发明涉及一般式(I)的化合物:其中:R1和R2,相同或不同,表示:氢或卤素原子,CN或NO2,但R1和R2不同时表示氢,m表示:1或2,n表示:0,1或2,R3表示:苯基,其中可以通过卤素,羟基或C1-C6烷基中的一个或多个残基进行取代或不取代;C2-C6烷基,其中可以通过卤素或羟基中的一个或多个残基进行取代或不取代;环烷基;吡啶;噻吩;取代或不取代的C1-C6烷基的吡咯;噻唑或呋喃;或其治疗可接受的盐或溶剂化合物。